FERRI, GIULIA
FERRI, GIULIA
DIPARTIMENTO DI FARMACIA
Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment
2024-01-01 Mucci, M; Recchiuti, A; Ripani, P; Romano, M; Di Sabatino, M; Collini, F; Ferri, G; Mattoscio, D
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer
2022-01-01 Mattoscio, Domenico; Ferri, Giulia; Miccolo, Claudia; Chiocca, Susanna; Romano, Mario; Recchiuti, Antonio
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy
2023-01-01 Ripani, Pietro; Mucci, Matteo; Pantano, Stefano; Di Sabatino, Maria; Collini, Francesca; Ferri, Giulia; Romano, Mario; Recchiuti, Antonio
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis
2023-01-01 Matte, Alessandro; B Wilson, Anand; Gevi, Federica; Federti, Enrica; Recchiuti, Antonio; Ferri, Giulia; Maria Brunati, Anna; Angelo Pagano, Mario; Russo, Roberta; Leboeuf, Christophe; Janin, Anne; Maria Timperio, Anna; Iolascon, Achille; Gremese, Elisa; Dang, Lenny; Mohandas, Narla; Brugnara, Carlo; De Franceschi, Lucia
REPURPOSING GALLIUM FOR LOCAL TREATMENT OF BACTERIAL PNEUMONIA THROUGH INHALABLE NANO-EMBEDDED MICROPARTICLES
2023-01-01 Costabile, G; Mitidieri, E; Visaggio, D; Ferri, G; D'Angelo, I; Frangipani, E; Bianca, Rdd; Recchiuti, A; Visca, P; Sorrentino, R; Ungaro, F
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease.
2023-01-01 Ferri, G; Serano, M; Isopi, E; Mucci, M; Mattoscio, D; Pecce, R; Protasi, F; Mall, Ma; Romano, M; Recchiuti, A.
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction
2022-01-01 Ferri, G; Isopi, E; Pecce, R; Mattoscio, D; Lamolinara, A; Iezzi, M; Mall, M; Romano, M; Recchiuti, A
Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis
2023-01-01 Mattoscio, D; Ferri, G; Mucci, M; Romano, M; Recchiuti, A
Specialized pro-resolving lipid mediators and resolution of viral diseases
2023-01-01 Ferri, Giulia; Mucci, Matteo; Mattoscio, Domenico; Recchiuti, Antonio
Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis
2024-01-01 D'Orazio, S; Mucci, M; Ferri, G; Tredicine, M; Ripani, P; Looney, M; Recchiuti, A; Mattoscio, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment | 2024 | Mucci, M; Recchiuti, A; Ripani, P; Romano, M; Di Sabatino, M; Collini, F; Ferri, G; Mattoscio, D | |
| Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer | 2022 | Mattoscio, Domenico; Ferri, Giulia; Miccolo, Claudia; Chiocca, Susanna; Romano, Mario; Recchiuti, Antonio | |
| Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy | 2023 | Ripani, Pietro; Mucci, Matteo; Pantano, Stefano; Di Sabatino, Maria; Collini, Francesca; Ferri, Giulia; Romano, Mario; Recchiuti, Antonio | |
| Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis | 2023 | Matte, Alessandro; B Wilson, Anand; Gevi, Federica; Federti, Enrica; Recchiuti, Antonio; Ferri, Giulia; Maria Brunati, Anna; Angelo Pagano, Mario; Russo, Roberta; Leboeuf, Christophe; Janin, Anne; Maria Timperio, Anna; Iolascon, Achille; Gremese, Elisa; Dang, Lenny; Mohandas, Narla; Brugnara, Carlo; De Franceschi, Lucia | |
| REPURPOSING GALLIUM FOR LOCAL TREATMENT OF BACTERIAL PNEUMONIA THROUGH INHALABLE NANO-EMBEDDED MICROPARTICLES | 2023 | Costabile, G; Mitidieri, E; Visaggio, D; Ferri, G; D'Angelo, I; Frangipani, E; Bianca, Rdd; Recchiuti, A; Visca, P; Sorrentino, R; Ungaro, F | |
| Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. | 2023 | Ferri, G; Serano, M; Isopi, E; Mucci, M; Mattoscio, D; Pecce, R; Protasi, F; Mall, Ma; Romano, M; Recchiuti, A. | |
| Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction | 2022 | Ferri, G; Isopi, E; Pecce, R; Mattoscio, D; Lamolinara, A; Iezzi, M; Mall, M; Romano, M; Recchiuti, A | |
| Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis | 2023 | Mattoscio, D; Ferri, G; Mucci, M; Romano, M; Recchiuti, A | |
| Specialized pro-resolving lipid mediators and resolution of viral diseases | 2023 | Ferri, Giulia; Mucci, Matteo; Mattoscio, Domenico; Recchiuti, Antonio | |
| Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis | 2024 | D'Orazio, S; Mucci, M; Ferri, G; Tredicine, M; Ripani, P; Looney, M; Recchiuti, A; Mattoscio, D |